SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Perceptive Advisors LLC, et al. – ‘4’ for 11/14/19 re: Agile Therapeutics Inc.

On:  Monday, 11/18/19, at 7:00pm ET   ·   For:  11/14/19   ·   Accession #:  899243-19-27548   ·   File #:  1-36464

Previous ‘4’:  ‘4’ on / for 11/18/19   ·   Next:  ‘4’ on 12/26/19 for 12/19/19   ·   Latest:  ‘4’ on 4/15/24 for 4/11/24

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/18/19  Perceptive Advisors LLC           4                      1:12K  Agile Therapeutics Inc.           Donnelley Fin’l S… 06/FA
          Perceptive Life Sciences Master Fund Ltd.
          Edelman Joseph

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Form 4 Submission -- doc4.xml/3.6                   HTML      3K


        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
Plain Text rendering:  Form 4 Submission
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0306
Document Type:  4
Period of Report:  11/14/19
Not Subject to Section 16:  0
Issuer:
Issuer CIK:  1261249
Issuer Name:  AGILE THERAPEUTICS INC
Issuer Trading Symbol:  AGRX
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1224962
Owner Name:  PERCEPTIVE ADVISORS LLC
Reporting Owner Address:
Owner Street 1:  51 ASTOR PLACE, 10TH FLOOR
Owner Street 2:
Owner City:  NEW YORK
Owner State:  NY
Owner ZIP Code:  10003
Owner State Description:
Reporting Owner Relationship:
Is Director?  No
Is Officer?  No
Is Ten Percent Owner?  Yes
Is Other?  No
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1249675
Owner Name:  PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
Reporting Owner Address:
Owner Street 1:  C/O PERCEPTIVE ADVISORS LLC
Owner Street 2:  51 ASTOR PLACE, 10TH FLOOR
Owner City:  NEW YORK
Owner State:  NY
Owner ZIP Code:  10003
Owner State Description:
Reporting Owner Relationship:
Is Director?  No
Is Officer?  No
Is Ten Percent Owner?  Yes
Is Other?  No
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1164426
Owner Name:  EDELMAN JOSEPH
Reporting Owner Address:
Owner Street 1:  C/O PERCEPTIVE ADVISORS LLC
Owner Street 2:  51 ASTOR PLACE, 10TH FLOOR
Owner City:  NEW YORK
Owner State:  NY
Owner ZIP Code:  10003
Owner State Description:
Reporting Owner Relationship:
Is Director?  No
Is Officer?  No
Is Ten Percent Owner?  Yes
Is Other?  No
Non-Derivative Table:
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  11/14/19
Deemed Execution Date:
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  P
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  435,015
Transaction Price Per Share:
Value:  1.69
Footnote ID:  F1
Transaction Acquired-Disposed Code:
Value:  A
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  6,586,125
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  See footnote
Footnote ID:  F3
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  11/15/19
Deemed Execution Date:
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  P
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  3,000,000
Transaction Price Per Share:
Value:  1.72
Transaction Acquired-Disposed Code:
Value:  A
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  9,586,125
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  See footnote
Footnote ID:  F3
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  11/15/19
Deemed Execution Date:
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  P
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  2,000,000
Transaction Price Per Share:
Value:  1.60
Transaction Acquired-Disposed Code:
Value:  A
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  11,586,125
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  See footnote
Footnote ID:  F3
Non-Derivative Transaction:
Security Title:
Value:  Common Stock
Transaction Date:
Value:  11/15/19
Deemed Execution Date:
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  P
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  333,800
Transaction Price Per Share:
Value:  1.74
Footnote ID:  F2
Transaction Acquired-Disposed Code:
Value:  A
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  11,919,925
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  See footnote
Footnote ID:  F3
Footnotes:
Footnote - F1:  The transaction was executed in multiple trades at prices ranging from $1.52 to $1.75. The price above reflects the weighted average price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
Footnote - F2:  The transaction was executed in multiple trades at prices ranging from $1.65 to $1.86. The price above reflects the weighted average price. Detailed information regarding the number of shares transacted at each separate price will be provided upon request by the Commission staff, the Issuer or a security holder of the Issuer.
Footnote - F3:  The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Remarks:
Owner Signature:
Signature Name:  /s/ Perceptive Life Sciences Master Fund Ltd., By: Perceptive Advisors LLC, its investment manager By: Joseph Edelman, its managing member
Signature Date:  11/18/19
Owner Signature:
Signature Name:  /s/ Perceptive Advisors LLC, By: Joseph Edelman, its managing member
Signature Date:  11/18/19
Owner Signature:
Signature Name:  /s/ Joseph Edelman
Signature Date:  11/18/19


↑Top
Filing Submission 0000899243-19-027548   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., Apr. 28, 4:38:26.2am ET